Go to content oder Go to navigation

News

Research news by our PharMetrX Research+ student Zrinka Duvnjak et al.

on the vedolizumab pharmacokinetics for pregnancy.

We are excited to share that our manuscript titled "Physiologically-motivated sequential population modeling of albumin trends and vedolizumab pharmacokinetics for pregnancy dosing regimen optimization" by Duvnjak et al. has been published in Clinical Pharmacology & Therapeutics. The paper has been highlighted in the editorial of this international highly recognised journal. Great work & collaboration!

back